XStAx-VHLL

• Description:

  XStAx-VHLL is a β-catenin PROTAC degrader that promotes ubiquitination and proteasome degradation of β-catenin. xStAx-VHLL inhibits the Wnt/β-catenin signaling pathway. xStAx-VHLL can inhibit the proliferation of colon cancer cells and has anti-tumor activity[1].

• UNSPSC:

  12352209

• Target:

  PROTACs; Wnt; β-catenin

• Type:

  Peptides

• Related Pathways:

  PROTAC; Stem Cell/Wnt

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/xstax-vhll.html

• Purity:

  99.37

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=C([C@H](CCCNC(N)=N)NC(C)=O)N[C@@H](CCCNC(N)=N)C(N[C@@H](CC1=CNC2=C1C=CC=C2)C(N3CCC[C@H]3C(N[C@@H](CCCNC(N)=N)C(N[C@](C(N[C@@H]([C@@H](C)CC)C(N[C@@H](CC(C)C)C(N[C@H]4CC(O)=O)=O)=O)=O)(CCC/C=C/CCC[C@@](C(N[C@@H](CC5=CN=CN5)C(N[C@@H](C(C)C)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](C(C)C)C(N[C@@H](CC6=CNC7=C6C=CC=C7)C(N[C@@H](CCCNC(N)=N)C(NCCCCCC(N[C@@H](C)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N8[C@H](C(N[C@@H](CC9=CC=C(C=C9)O)C(N[C@@H]([C@@H](C)CC)C(N%10[C@H](C(N)=O)CCC%10)=O)=O)=O)CCC8)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)(NC4=O)C)C)=O)=O)=O)=O

• Molecular Formula:

  C154H244N48O29

• Molecular Weight:

  3231.89

• References & Citations:

  [1]Liao H, et al. A PROTAC peptide induces durable β-catenin degradation and suppresses Wnt-dependent intestinal cancer. Cell Discov. 2020 Jun 9;6:35.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)

• Scientific Category:

  Peptides

• Clinical Information:

  No Development Reported